LEYKEMIYA – SARATON HUJAYRALARINI TANLAB YO’Q QILUVCHI NANO ZARRACHAALAR YARATISH
;
Leykemiya, CLL, AML, apoptozni qo'zg'atuvchi ligand, CD13 oqsili, AaLS oqsil, aCD13Nb nanozarrasi.Abstrak
Hozirgi vaqtda butun dunyo bo’ylab leykemiya-oq qon kasalligini davolash hamda inson umrini uzaytirishga qaratilgan ilmiy izlanishlar jadal miqyosda olib borilmoqda.Rivojlangan mamlakatlardagi leykemiya turiga qarab besh yil ichida omon qolish darajasi 60% yoki hatto 90% dan oshadi. Bemorlarning besh yildan keyin butunlay tuzalib ketishi deyarli kuzatilmagan. 2015-yilda leykemiya butun dunyo boʻylab 2,3 million odamda aniqlangan va shulardan 353500 bemorning oʻlimi bilan yakun topgan. Koreyanining Ulsan Milliy Fan va Texnologiyalar Universiteti tadqiqot guruhi olimlari o'tkir miyeloid leykemiyani samarali davolovchi nano zarrachalarni ishlab chiqdi, bu esa bevosita leykemiya hujayralarini tanlab yo'q qilish orqali terapevtik samaradorlikni oshirish va yon ta'sirlarni kamaytirish imkoniyatini beradi.
Iqtiboslar
Indu Khurana, Arushi Khurana: Textbook of medical physiology; 2nd edition, 2009.
"What You Need To Know About™ Leukemia". National Cancer Institute. 23 December 2013. Archived from the original on 6 July 2014. Retrieved 18 June 2014.
American Cancer Society (2 March 2014). "Survival rates for childhood leukemia". Archived from the original on 14 July 2014.
Nanoparticle technology demonstrates selective destruction of leukemia cancer cells by JooHyeon Heo, Ulsan National Institute of Science and Technology Bio & Medicine 22 october 2024
https://phys.org/news/2024-10-nanoparticle-technologydestruction-leukemia-cancer.html
